A PHASE 1, MULTICENTER, OPEN‐LABEL STUDY OF CC‐99282 ALONE AND IN COMBINATION WITH RITUXIMAB IN PATIENTS WITH RELAPSED OR REFRACTORY NON‐HODGKIN LYMPHOMAS.
| Autor: | Michot, J.‐M., Carpio, C., Nastoupil, L., Chavez, J., Feldman, T., Ferrari, S., Morillo, D., Bachy, E., Pinto, A., Kuruvilla, J., Buchholz, T. J., Kasibhatla, S., Carrancio, S., Guarinos, C., Wu, F., Li, S., Patah, P., Pourdehnad, M. |
|---|---|
| Zdroj: | Hematological Oncology; Jun2021 Supplement S2, Vol. 39, p1-3, 3p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|
Plný text